Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LyondellBasell Industries
LYB
|
+$492M |
| 2 |
LLL
L3 Technologies, Inc.
LLL
|
+$392M |
| 3 |
Apple
AAPL
|
+$245M |
| 4 |
AGN
Allergan plc
AGN
|
+$238M |
| 5 |
NXP Semiconductors
NXPI
|
+$226M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$568M |
| 2 |
Coty
COTY
|
+$491M |
| 3 |
APC
Anadarko Petroleum
APC
|
+$224M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$211M |
| 5 |
Sysco
SYY
|
+$208M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.12% |
| 2 | Technology | 11.12% |
| 3 | Financials | 10.62% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Industrials | 7.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Sun Life Financial
SLF
$46.6B
| $537K | ﹤0.01% |
12,978
-22,223
| -63% | -$893K |
|
|
PBCT
3152
DELISTED
People's United Financial Inc
PBCT
| $536K | ﹤0.01% |
+31,967
| New | +$531K |
|
3153
BlackRock Enhanced Captial and Income Fund
CII
$980M
| $535K | ﹤0.01% |
+33,862
| New | +$534K |
|
3154
CorMedix
CRMD
$575M
| $535K | ﹤0.01% |
59,637
-171,286
| -74% | -$1.34M |
|
|
BRQS
3155
DELISTED
Borqs Technologies, Inc. Ordinary Shares
BRQS
| $535K | ﹤0.01% |
1,114
-13
| -1% | -$9.15K |
|
3156
Arcosa
ACA
$7.14B
| $532K | ﹤0.01% |
14,128
-258,555
| -95% | -$8.84M |
|
3157
Dycom Industries
DY
$12.1B
| $532K | ﹤0.01% |
9,045
-195,033
| -96% | -$9.98M |
|
|
EIM
3158
Eaton Vance Municipal Bond Fund
EIM
$494M
| $531K | ﹤0.01% |
+42,712
| New | +$532K |
|
3159
Quince Therapeutics
QNCX
$18.9M
| $531K | ﹤0.01% |
+62
| New | +$370K |
|
3160
Gran Tierra Energy
GTE
$226M
| $530K | ﹤0.01% |
33,320
+27,293
| +453% | +$581K |
|
|
HES
3161
DELISTED
Hess
HES
| $530K | ﹤0.01% |
8,336
-16,093
| -66% | -$995K |
|
3162
Cato Corp
CATO
$67.5M
| $529K | ﹤0.01% |
42,971
-171,314
| -80% | -$2.33M |
|
3163
iShares Core MSCI Emerging Markets ETF
IEMG
$147B
| $526K | ﹤0.01% |
+10,230
| New | +$523K |
|
|
VIVS
3164
VivoSim Labs
VIVS
$1.32M
| $526K | ﹤0.01% |
+4,188
| New | +$791K |
|
3165
Southern Missouri Bancorp
SMBC
$868M
| $525K | ﹤0.01% |
15,076
+2,336
| +18% | +$76.7K |
|
3166
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.69B
| $525K | ﹤0.01% |
385
-710
| -65% | -$938K |
|
3167
AutoZone
AZO
$50.9B
| $524K | ﹤0.01% |
477
-653
| -58% | -$687K |
|
|
ALYA
3168
DELISTED
Alithya Group Inc Class A Subordinate Voting Shares
ALYA
| $524K | ﹤0.01% |
200,180
+147,613
| +281% | +$447K |
|
3169
BlackRock Taxable Municipal Bond Trust
BBN
$976M
| $523K | ﹤0.01% |
22,034
+11,891
| +117% | +$275K |
|
|
BZUN
3170
Baozun
BZUN
$168M
| $522K | ﹤0.01% |
10,468
-107,442
| -91% | -$4.64M |
|
|
CUK
3171
DELISTED
Carnival PLC
CUK
| $522K | ﹤0.01% |
11,523
+5,923
| +106% | +$304K |
|
3172
ReposiTrak
TRAK
$159M
| $522K | ﹤0.01% |
+97,476
| New | +$647K |
|
|
ABMD
3173
CALL
DELISTED
Abiomed Inc
ABMD
| $521K | ﹤0.01% |
2,000
-3,500
| -64% | -$929K |
|
3174
Mercantile Bank Corp
MBWM
$1.04B
| $520K | ﹤0.01% |
15,956
-1,627
| -9% | -$53.3K |
|
3175
Spyre Therapeutics
SYRE
$8.68B
| $520K | ﹤0.01% |
3,035
+2,454
| +422% | +$424K |
|
Similar funds
Millennium Management's Q2 2019 Portfolio in Review
As of Q2 2019, Millennium Management held 4,801 positions worth $66.5B, down 0.45% from $66.8B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.
Millennium Management's Q2 2019 filing shows 865 new, 1,488 increased, 1,571 reduced and 810 closed positions. Its largest new stake was Moody's: 638,271 shares worth $125M. The largest sale was Walt Disney, an estimated $568M.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.
- Millennium Management's largest Q2 2019 buy was Moody's: 638,271 shares worth $125M.
- Millennium Management added most to LyondellBasell Industries in Q2 2019, an estimated $492M increase.
- Millennium Management's biggest Q2 2019 reduction was Walt Disney, cutting an estimated $568M.
- Millennium Management fully exited Sysco in Q2 2019, selling an estimated $208M.
- Millennium Management's ten largest holdings make up 7.7% of its $66.5B portfolio in Q2 2019.
- Millennium Management opened 865 new positions and closed 810 in Q2 2019.
- Millennium Management's portfolio value fell 0.45% quarter-over-quarter to $66.5B.
Based on Millennium Management's 13F filing for Q2 2019, filed 14 Aug 2019.